CS logo
small CS logo
Altana Pharma/Nycomed

Seoul, Korea, Republic of

About Altana Pharma/Nycomed


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Altana Pharma/Nycomed


During the past decade, Altana Pharma/Nycomed conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110
2002-06-01
2014-03-01
Completed
500
Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy
2004-05-01
2016-05-01
Completed
200
Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)
2002-09-01
2010-02-01
Completed
300
A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer
2005-11-01
2015-04-01
Completed
316
Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients
2005-11-01
2006-08-01
Completed
85
A Study of Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukaemia
2010-08-01
2011-05-01
Completed
7
Clinical Study to Investigate the Efficacy and the Safety of DA-9501 in Sedation During the Surgery or Medical Procedure Without Intubation
2011-07-01
2012-03-01
Completed
162
A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma
2012-11-12
2017-03-21
Completed
26

Rows per page:

1–11 of 11

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Altana Pharma/Nycomed


According to Clinical.Site data, the most researched conditions in "Altana Pharma/Nycomed" are "Asthma" (1 trials), "COPD" (1 trials) and "Gastroesophageal Reflux Disease (GERD)" (1 trials). Many other conditions were trialed in "Altana Pharma/Nycomed" in a lesser frequency.

Clinical Trials Intervention Types at Altana Pharma/Nycomed


Most popular intervention types in "Altana Pharma/Nycomed" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Ciclesonide" (1 trials), "Pantoprazole" (1 trials), "Placebo" (1 trials) and "Roflumilast" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Altana Pharma/Nycomed


The vast majority of trials in "Altana Pharma/Nycomed" are 3 trials for "All" genders.

Clinical Trials Status at Altana Pharma/Nycomed


Currently, there are NaN active trials in "Altana Pharma/Nycomed". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Altana Pharma/Nycomed, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Altana Pharma/Nycomed, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status